Conditions: Partial Epilepsies
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 370
Healthy volunteers: no

Brief summary:
The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.

Detailed description:

Arms:
arm 1: 50mg and 100mg tablets up to 800 mg/day as twice a day (BID) dosing

Interventions: intervention 1: lacosamide
Intervention descriptions: intervention 1: 50mg and 100mg tablets up to 800 mg/day as twice a day (BID) dosing throughout the trial

Protocol document: